| Product | Indications | Preclinical | Phase 1 | Phase 2 | Phase 3 | Status |
|---|---|---|---|---|---|---|
Validive® |
Radiation induced SOM in OPC |
Preclinical complete |
Phase 1 complete |
Phase 2 in progress |
Phase 3 not started |
Completed Phase 2 Trial, Phase 2b/3 starting H2 2020 |
Camsirubicin |
Advanced Soft Tissue Sarcoma |
Preclinical complete |
Phase 1 complete |
Phase 2 in progress |
Phase 3 not started |
Completed Phase 2 in Soft Tissue Sarcoma, Collaboration with GEIS for larger Phase 2 |
MNPR-101 |
Severe COVID-19 |
Preclinical in progress |
Phase 1 not started |
Phase 2 not started |
Phase 3 not started |
Collaboration with NorthStar for severe COVID-19 |
MNPR-101 |
Advanced Solid Cancers |
Preclinical in progress |
Phase 1 not started |
Phase 2 not started |
Phase 3 not started |
Pre-IND |
